Skip to main content
IDEXX LABORATORIES INC /DE logo

IDEXX LABORATORIES INC /DE — Investor Relations & Filings

Ticker · IDXX ISIN · US45168D1046 LEI · OGMTXK0LUU1HKV2P0J84 US Professional, scientific and technical activities
Open in API
Filings indexed 1,395 across all filing types
Latest filing 2025-04-24 Regulatory Filings
Country US United States of America
Listing US IDXX

About IDEXX LABORATORIES INC /DE

https://www.idexx.com/

IDEXX Laboratories, Inc. is a global leader in diagnostics and software for the veterinary, livestock, and water testing markets. The company develops, manufactures, and distributes a broad range of products and services aimed at enhancing the health and well-being of pets, people, and livestock. Core offerings include in-clinic point-of-care diagnostic instruments and tests, a global network of reference laboratories providing advanced testing services, and practice management software solutions for veterinarians. These integrated solutions provide veterinarians with actionable insights to deliver advanced medical care and improve practice efficiency.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2025
Regulatory Filings
2025-04-24 English
Major Shareholding Notification 2025
Major Shareholding Notification
2025-04-17 English
ARS
Annual Report
2025-03-28 English
DEFA14A
Proxy Solicitation & Information Statement Classification · 100% confidence The document is identified as a Schedule 14A filing, which is a Proxy Statement pursuant to Section 14(a) of the Securities Exchange Act of 1934. The text includes terms such as 'Proxy Statement,' 'Definitive Proxy Statement,' and 'Definitive Additional Materials,' which are typical for proxy solicitation documents. The document length is short (1052 characters), and it appears to be a filing related to shareholder voting and proxy solicitation rather than a full report or financial statement. Therefore, the document fits the category of Proxy Solicitation & Information Statement (PSI).
2025-03-28 English
DEF 14A
Proxy Solicitation & Information Statement
2025-03-28 English
PRE 14A
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Schedule 14A Proxy Statement filed with the SEC by IDEXX Laboratories, Inc. It includes detailed information about the upcoming 2025 Annual Meeting of Shareholders, including voting matters, board of directors election, executive compensation, corporate governance, and other shareholder-related information. The document is not an annual report, earnings release, or financial statement but rather a solicitation of shareholder votes and information related to the annual meeting. The presence of detailed governance, director nominations, and compensation discussions aligns with the definition of Proxy Solicitation & Information Statement (PSI). The document length (15,000 characters) and content confirm it is the proxy statement itself, not just an announcement or a brief summary.
2025-03-14 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.